04/11/2024
3:43 PM | Onconetix, Inc. (Filer)
Onconetix (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/13/2024
3:59 PM | Onconetix, Inc. (Filer)
Onconetix (Filer)
| Form 8-K/A | |
02/13/2024
7:24 AM | Onconetix, Inc. (Filer)
Onconetix (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/12/2024
3:30 PM | Onconetix, Inc. (Filer)
Onconetix (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/01/2024
4:09 PM | Onconetix, Inc. (Filer)
Onconetix (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
01/29/2024
3:30 PM | Onconetix, Inc. (Filer)
Onconetix (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/26/2024
5:01 AM | AMERICAN FINANCIAL GROUP INC (Filed by)
Onconetix, Inc. (Subject)
Onconetix (Subject)
| Form SC 13G/A | |
|
01/19/2024
3:05 PM | Onconetix, Inc. (Filer)
Onconetix (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/12/2024
3:51 PM | Onconetix, Inc. (Filer)
Onconetix (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/02/2024
12:13 PM | Onconetix, Inc. (Subject)
Onconetix (Subject)
SABBY MANAGEMENT, LLC (Filed by)
| Form SC 13G/A | |
12/28/2023
3:53 PM | Bruhlmann Christian (Reporting)
Onconetix, Inc. (Issuer)
Onconetix (Issuer)
Onconetix, Inc. (Issuer)
Onconetix (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
12/27/2023
5:34 PM | Altos Venture AG (Filed by)
Onconetix, Inc. (Subject)
Onconetix (Subject)
| Form SC 13G | |
12/27/2023
3:51 PM | Onconetix, Inc. (Filer)
Onconetix (Filer)
| Form 8-K/A | |
12/21/2023
3:56 PM | Onconetix, Inc. (Filer)
Onconetix (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/19/2023
7:00 AM | Onconetix, Inc. (Filer)
Onconetix (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/18/2023
7:11 AM | Blue Water Biotech, Inc. (Filer)
Onconetix (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/17/2023
4:23 PM | Blue Water Biotech, Inc. (Filer)
Onconetix (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/14/2023
6:38 PM | Blue Water Biotech, Inc. (Filer)
Onconetix (Filer)
| Form NT 10-Q | |
11/01/2023
7:15 PM | Blue Water Biotech, Inc. (Filer)
Onconetix (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/30/2023
8:58 AM | Blue Water Biotech, Inc. (Filer)
Onconetix (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/20/2023
4:12 PM | Blue Water Biotech, Inc. (Filer)
Onconetix (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
10/18/2023
4:00 PM | Blue Water Biotech, Inc. (Filer)
Onconetix (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/10/2023
5:48 PM | Blue Water Biotech, Inc. (Issuer)
Onconetix (Issuer)
Harmon Bruce (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
10/10/2023
5:49 PM | Blue Water Biotech, Inc. (Issuer)
Onconetix (Issuer)
CAMPBELL NEIL J (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
10/10/2023
8:08 AM | Blue Water Biotech, Inc. (Filer)
Onconetix (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/03/2023
7:01 AM | Blue Water Biotech, Inc. (Filer)
Onconetix (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/22/2023
3:41 PM | Blue Water Biotech, Inc. (Filer)
Onconetix (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/28/2023
3:30 PM | Blue Water Biotech, Inc. (Filer)
Onconetix (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/22/2023
4:27 PM | Blue Water Biotech, Inc. (Filer)
Onconetix (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/15/2023
4:22 PM | Blue Water Biotech, Inc. (Filer)
Onconetix (Filer)
| Form NT 10-Q | |
08/10/2023
8:15 AM | Blue Water Biotech, Inc. (Filer)
Onconetix (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/03/2023
1:29 PM | Blue Water Biotech, Inc. (Filer)
Onconetix (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/01/2023
7:25 AM | Blue Water Biotech, Inc. (Filer)
Onconetix (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/31/2023
8:00 AM | Blue Water Biotech, Inc. (Filer)
Onconetix (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/25/2023
8:55 AM | Blue Water Biotech, Inc. (Filer)
Onconetix (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/17/2023
8:05 AM | Blue Water Biotech, Inc. (Filer)
Onconetix (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/11/2023
8:06 AM | Blue Water Biotech, Inc. (Filer)
Onconetix (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/06/2023
4:00 PM | Blue Water Biotech, Inc. (Filer)
Onconetix (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/06/2023
4:11 PM | Blue Water Biotech, Inc. (Filer)
Onconetix (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/06/2023
6:40 AM | Blue Water Biotech, Inc. (Filer)
Onconetix (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/29/2023
9:34 AM | Blue Water Biotech, Inc. (Subject)
Onconetix (Subject)
Cincinnati Cornerstone Investors BWV I, LLC (Filed by)
| Form SC 13D | |
Better than Bitcoin? The Biotech Stock with 46,751% Potential (Ad) 4x Better than Bitcoin
Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December. Get the name of the stock here >>> |
06/28/2023
7:00 AM | Blue Water Biotech, Inc. (Filer)
Onconetix (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/21/2023
6:30 AM | Blue Water Biotech, Inc. (Filer)
Onconetix (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/14/2023
7:03 AM | Blue Water Biotech, Inc. (Filer)
Onconetix (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/06/2023
3:40 PM | Blue Water Biotech, Inc. (Filer)
Onconetix (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/01/2023
8:10 PM | Blue Water Biotech, Inc. (Issuer)
Onconetix (Issuer)
SAPIRSTEIN JAMES (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/01/2023
8:10 PM | Blue Water Biotech, Inc. (Issuer)
Onconetix (Issuer)
Tarsh Simon (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/01/2023
8:11 PM | Blue Water Biotech, Inc. (Issuer)
Onconetix (Issuer)
Ramdeen Timothy R. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/01/2023
8:11 PM | Blue Water Biotech, Inc. (Issuer)
Onconetix (Issuer)
Jeremic Vuk (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/15/2023
8:12 AM | Blue Water Biotech, Inc. (Filer)
Onconetix (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/12/2023
4:30 PM | Blue Water Biotech, Inc. (Filer)
Onconetix (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/11/2023
8:18 PM | Blue Water Biotech, Inc. (Issuer)
Onconetix (Issuer)
Henderson Erin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/11/2023
8:21 PM | Blue Water Biotech, Inc. (Issuer)
Onconetix (Issuer)
Garfield Jon (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/11/2023
8:22 PM | Blue Water Biotech, Inc. (Issuer)
Onconetix (Issuer)
Hernandez Joseph (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/10/2023
12:01 PM | Blue Water Biotech, Inc. (Filer)
Onconetix (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/04/2023
11:15 PM | Blue Water Biotech, Inc. (Filer)
Onconetix (Filer)
| Form EFFECT | |
04/28/2023
4:12 PM | Blue Water Biotech, Inc. (Filer)
Onconetix (Filer)
| Form POS AM | |
04/26/2023
4:22 PM | Blue Water Biotech, Inc. (Filer)
Onconetix (Filer)
| Form DEF 14A | |
